ASX:BIT

Biotron (BIT) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.03 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
5.08%
Price Target
N/A
BIT stock logo

About Biotron Stock (ASX:BIT)

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.

BIT Stock News Headlines

BBC micro:bit playground survey
The Department of Defense Has a New Drone Contractor
The Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.
The Department of Defense Has a New Drone Contractor
The Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.
The Best Multi-Bit Screwdriver
BBC micro:bit - the next gen
Biotron Limited (BIT.AX)
Biotron Drug Effective Against COVID-19 In Animals
See More Headlines
Receive BIT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$-4,020,000.00
Net Margins
-244.54%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.65 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.59
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Dr. Michelle Miller BSc.
    GCertAppFin, MSc., Ph.D., MD & Executive Director
  • Mr. Peter James Nightingale B.Econ (Age 67)
    CA, Company Secretary
    Comp: $120k
  • Dr. Stephen L. Becker M.D.
    Chief Medical Officer

BIT Stock Analysis - Frequently Asked Questions

This page (ASX:BIT) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners